PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $217,340 | -2.3% | 5,424 | -0.5% | 0.00% | +33.3% |
Q1 2023 | $222,415 | +8.2% | 5,450 | +2.4% | 0.00% | 0.0% |
Q4 2022 | $205,521 | -27.4% | 5,323 | -0.1% | 0.00% | -25.0% |
Q3 2022 | $283,000 | -3.1% | 5,328 | +6.5% | 0.00% | 0.0% |
Q2 2022 | $292,000 | -23.6% | 5,004 | +0.1% | 0.00% | -20.0% |
Q1 2022 | $382,000 | +26.9% | 5,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $301,000 | +7.5% | 5,000 | 0.0% | 0.01% | +25.0% |
Q3 2021 | $280,000 | -7.6% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $303,000 | -13.4% | 5,000 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $350,000 | +17.1% | 5,000 | 0.0% | 0.01% | +25.0% |
Q4 2020 | $299,000 | -0.7% | 5,000 | 0.0% | 0.00% | -20.0% |
Q3 2020 | $301,000 | +14.9% | 5,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $262,000 | +15.4% | 5,000 | 0.0% | 0.01% | +25.0% |
Q4 2019 | $227,000 | +4.6% | 5,000 | 0.0% | 0.00% | -42.9% |
Q2 2019 | $217,000 | +0.9% | 5,000 | 0.0% | 0.01% | -22.2% |
Q4 2018 | $215,000 | -12.6% | 5,000 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $246,000 | +11.8% | 5,000 | -29.3% | 0.01% | +12.5% |
Q1 2018 | $220,000 | -28.3% | 7,075 | +5.2% | 0.01% | -33.3% |
Q4 2017 | $307,000 | +22.8% | 6,725 | +1.1% | 0.01% | +20.0% |
Q3 2017 | $250,000 | -21.1% | 6,650 | 0.0% | 0.01% | -16.7% |
Q2 2017 | $317,000 | – | 6,650 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |